ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.

"Declarations Ethics approval and consent to participateThe protocols used in this study were approved by the Ethical Review Committees of West China Hospital, Sichuan University (No. 2017-324), and written informed consent was provided by all the patients. The animal studies were authorized by the Animal Ethics Review Committees of the West China Hospital, China (No. 20170125252). All animal experiments were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This study was supported by the National Key R&D Plan (2023YFC3403200), the National Natural Science Foundation of China (82070784, 81702536, 81974099 and 82170785), the Science & Technology Department of Sichuan Province, China (2022JDRC0040, 21GJHZ0246), the Young Investigator Award of Sichuan University 2017 (2017SCU04A17), the Sichuan University-Panzhihua Science and Technology Cooperation Special Fund (2020CDPZH-4), the China Postdoctoral Science Foundation (2021M692306), and Post-Doctor Research Project of West China Hospital of Sichuan University (2021HXBH025)."